Company News, Financial News

Novozymes Sales Rise 7% in 2012

Author Image

By: TOM BRANNA

Editor

• Novozymes’s 2012 sales rose 7% to more than $2.0 billion, the company reported. Net profit rose 10% to nearly $360 million. This year, the company expects organic sales growth of 5-8%. “We delivered strong earnings growth and record profitability in a year when organic sales growth was challenged and came in at 4%—below our ambition,” said Steen Riisgaard, president and CEO. “With 2012 behind us, we have reviewed our long-term growth scenarios and decided to adjust our long-term financial tar...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters